Retroviral Integrase: Difference between revisions
From Proteopedia
Jump to navigationJump to search
Michal Harel (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
| Line 6: | Line 6: | ||
HIV Integrase inhibitors: [http://www.isentress.com Raltegravir], marketed as Isentress is currently approved as a therapeutic inhibitor of HIV integrase. It was approved on October 12, 2007. | HIV Integrase inhibitors: [http://www.isentress.com Raltegravir], marketed as Isentress is currently approved as a therapeutic inhibitor of HIV integrase. It was approved on October 12, 2007. | ||
[See below for a table of antiretroviral drugs with trade name, company, patents, and notes.] | [See below for a table of antiretroviral drugs with trade name, company, patents, and notes.] | ||
For '''phage integrase''' see [[Phage integrase]]. | |||
==Mechanism for strand-transfer inhibition actio== | ==Mechanism for strand-transfer inhibition actio== | ||
